行情

XXII

XXII

22世纪集团
AMEX

实时行情|Nasdaq Last Sale

0.6924
+0.0123
+1.81%
交易中 12:31 04/02 EDT
开盘
0.6837
昨收
0.6801
最高
0.7210
最低
0.6800
成交量
39.04万
成交额
--
52周最高
2.460
52周最低
0.6000
市值
9,614.45万
市盈率(TTM)
-3.2815
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测XXII价格均价为11.50,最高价位11.50,最低价为11.50。

EPS

XXII 新闻

更多
  • Does The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Price Fall With The Market?
  • Simply Wall St. · 03/23 14:08
  • 22nd Century Group, Inc. Files 2019 Annual Report
  • Business Wire · 03/12 11:50
  • 22ND Century Group Net Sales Revenue For Q4 Increased To $7.3M
  • Benzinga · 03/12 10:58
  • 22nd Century Announces Important New Achievements with KeyGene
  • GlobeNewswire · 03/11 21:15

所属板块

环保服务及设备
+1.30%
专业与商业服务
+1.14%

热门股票

代码
价格
涨跌幅

XXII 简况

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
展开

微牛提供22nd Century Group Inc(AMEX-XXII)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的XXII股票新闻,以帮助您做出投资决策。